Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
grade A 52.615 0.18% 0.10
NVO closed down 0.3 percent on Friday, October 18, 2019, on 57 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NVO trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.18%
Pocket Pivot Bullish Swing Setup -0.12%
Narrow Range Bar Range Contraction -0.12%
NR7 Range Contraction -0.12%
Overbought Stochastic Strength -0.12%
Stochastic Reached Overbought Strength 0.62%
Outside Day Range Expansion 0.62%
Overbought Stochastic Strength 0.62%
Crossed Above 20 DMA Bullish 1.12%
Crossed Above 50 DMA Bullish 1.12%

Older signals for NVO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Life Sciences Diabetes Pharmaceutical Products Inflammation Obesity Endocrine System Hormones Insulin Peptide Hormones Biopharmaceuticals Diabetes Care Glucagon Like Peptide 1 Anti Diabetic Drugs Hormone Therapy
Is NVO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 53.55
52 Week Low 41.59
Average Volume 1,370,766
200-Day Moving Average 49.8801
50-Day Moving Average 51.5992
20-Day Moving Average 51.7985
10-Day Moving Average 51.987
Average True Range 0.7761
ADX 10.12
+DI 30.0283
-DI 27.6621
Chandelier Exit (Long, 3 ATRs ) 51.0817
Chandelier Exit (Short, 3 ATRs ) 51.8283
Upper Bollinger Band 53.4417
Lower Bollinger Band 50.1553
Percent B (%b) 0.72
BandWidth 6.344585
MACD Line 0.2784
MACD Signal Line 0.1574
MACD Histogram 0.1209
Fundamentals Value
Market Cap 130.26 Billion
Num Shares 2.48 Billion
EPS 2.49
Price-to-Earnings (P/E) Ratio 21.09
Price-to-Sales 6.57
Price-to-Book 15.49
PEG Ratio 2.42
Dividend 0.95
Dividend Yield 1.81%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 53.24
Resistance 3 (R3) 53.20 52.92 53.12
Resistance 2 (R2) 52.92 52.74 52.94 53.08
Resistance 1 (R1) 52.72 52.63 52.58 52.76 53.04
Pivot Point 52.45 52.45 52.38 52.46 52.45
Support 1 (S1) 52.24 52.26 52.11 52.28 52.00
Support 2 (S2) 51.97 52.15 51.99 51.96
Support 3 (S3) 51.77 51.97 51.92
Support 4 (S4) 51.80